中基健康
(000972)
| 流通市值：17.43亿 | | | 总市值：17.43亿 |
| 流通股本：7.71亿 | | | 总股本：7.71亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 119,254,852.12 | 575,779,449.91 | 343,059,838.58 | 287,923,679.18 |
| 营业收入 | 119,254,852.12 | 575,779,449.91 | 343,059,838.58 | 287,923,679.18 |
| 二、营业总成本 | 113,703,122.68 | 516,556,329.44 | 293,225,200.16 | 237,737,588.49 |
| 营业成本 | 97,085,570.65 | 430,214,558.24 | 244,939,627.78 | 206,980,861.81 |
| 税金及附加 | 88,350.97 | 6,295,336.71 | 3,652,653.25 | 2,413,373.66 |
| 销售费用 | 1,443,880.32 | 11,325,318.11 | 3,628,371.97 | 1,545,703.74 |
| 管理费用 | 9,342,827.73 | 48,695,585.84 | 30,288,829.75 | 21,525,253.7 |
| 研发费用 | 352,972.67 | 827,843.81 | 456,285.7 | - |
| 财务费用 | 5,389,520.34 | 19,197,686.73 | 10,259,431.71 | 5,272,395.58 |
| 其中:利息费用 | 6,335,081.78 | 22,023,665.98 | 13,404,543.9 | 8,375,952.66 |
| 其中:利息收入 | -82,722.5 | 1,909,870.46 | 1,613,461.59 | 1,322,176.06 |
| 加:投资收益 | - | - | -2,533.93 | 8,561.47 |
| 资产处置收益 | 783,776.41 | 40,567,551.53 | 371,588.33 | 246,005.65 |
| 资产减值损失(新) | - | -206,443.89 | - | - |
| 信用减值损失(新) | -857,394.97 | -13,040,006.02 | -6,949,191.47 | -12,470,945.7 |
| 其他收益 | 859,834.1 | 2,072,561.48 | 555,440.19 | 188,420.9 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 6,337,944.98 | 88,616,783.57 | 43,809,941.54 | 38,158,133.01 |
| 加:营业外收入 | 57,398.89 | 21,163,388.7 | 273,006.78 | 197,536.11 |
| 减:营业外支出 | 12,020.49 | 413,671.75 | 361,474.09 | 118,500.18 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 6,383,323.38 | 109,366,500.52 | 43,721,474.23 | 38,237,168.94 |
| 减:所得税费用 | 203,556.59 | 219,125.81 | 556,472.43 | 26,854.83 |
| 六、净利润 | 6,179,766.79 | 109,147,374.71 | 43,165,001.8 | 38,210,314.11 |
| 持续经营净利润 | 6,179,766.79 | 109,147,374.71 | 43,165,001.8 | 38,210,314.11 |
| 归属于母公司股东的净利润 | 5,982,705.03 | 108,237,777.85 | 43,011,601.53 | 38,087,031.59 |
| 少数股东损益 | 197,061.76 | 909,596.86 | 153,400.27 | 123,282.52 |
| (一)基本每股收益 | 0.01 | 0.14 | 0.06 | 0.05 |
| (二)稀释每股收益 | 0.01 | 0.14 | 0.06 | 0.05 |
| 八、其他综合收益 | - | -112,470.26 | - | - |
| 归属于母公司股东的其他综合收益 | - | -112,470.26 | - | - |
| 九、综合收益总额 | 6,179,766.79 | 109,034,904.45 | 43,165,001.8 | 38,210,314.11 |
| 归属于母公司股东的综合收益总额 | 5,982,705.03 | 108,125,307.59 | 43,011,601.53 | 38,087,031.59 |
| 归属于少数股东的综合收益总额 | 197,061.76 | 909,596.86 | 153,400.27 | 123,282.52 |
| 公告日期 | 2024-04-25 | 2024-03-19 | 2023-10-28 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |